These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24887383)

  • 41. Rituximab in steroid refractory autoimmune hemolytic anemia.
    Gupta N; Sharma S; Seth T; Mishra P; Mahapatra M; Kumar S; Kapoor R; Agarwal N
    Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.
    Raj A; Bertolone S; Cheerva A
    J Pediatr Hematol Oncol; 2004 May; 26(5):312-4. PubMed ID: 15111785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
    D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
    Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
    Wang M; Wang W; Abeywardane A; Adikarama M; McLornan D; Raj K; de Lavallade H; Devereux S; Mufti GJ; Pagliuca A; Potter VT; Mijovic A
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):60-6. PubMed ID: 25262883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection risk in autoimmune hematological disorders with low-dose rituximab treatment.
    Wang H; Yan S; Liu H; Li L; Song J; Wang G; Wang H; Wu Y; Shao Z; Fu R
    J Clin Lab Anal; 2020 Oct; 34(10):e23455. PubMed ID: 32794271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
    O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
    Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
    Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.
    Teshima T; Nagafuji K; Henzan H; Miyamura K; Takase K; Hidaka M; Miyamoto T; Takenaka K; Akashi K; Harada M
    Int J Hematol; 2009 Sep; 90(2):253-260. PubMed ID: 19543951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
    Rao VK; Price S; Perkins K; Aldridge P; Tretler J; Davis J; Dale JK; Gill F; Hartman KR; Stork LC; Gnarra DJ; Krishnamurti L; Newburger PE; Puck J; Fleisher T
    Pediatr Blood Cancer; 2009 Jul; 52(7):847-52. PubMed ID: 19214977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study.
    Kim SJ; Lee JW; Jung CW; Min CK; Cho B; Shin HJ; Chung JS; Kim H; Lee WS; Joo YD; Yang DH; Kook H; Kang HJ; Ahn HS; Yoon SS; Sohn SK; Min YH; Min WS; Park HS; Won JH
    Haematologica; 2010 Nov; 95(11):1935-42. PubMed ID: 20663943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.
    Moriya K; Matsuhashi T; Onuma M; Niizuma H; Rikiishi T; Asada H; Suzuki J; Sasahara Y; Kure S
    Int J Hematol; 2013 Aug; 98(2):237-9. PubMed ID: 23702915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].
    Gil-Fernández JJ; Flores Ballester E; González Martínez M; Arévalo-Serrano J; Tamayo Martín AT; Burgaleta Alonso de Ozalla C
    Med Clin (Barc); 2013 Sep; 141(5):201-4. PubMed ID: 22857805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
    Valent P; Lechner K
    Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice.
    Červinek L; Černá O; Čaniga M; Konířová E; Hluší A; Šimkovič M; Pospíšil Z; Čermák J; Kozák T; Mayer J; Doubek M
    Int J Hematol; 2012 Nov; 96(5):594-9. PubMed ID: 23099924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation.
    Yoshida S; Ohno Y; Nagafuji K; Yoshimoto G; Sugio T; Kamimura T; Ohta T; Takase K; Henzan H; Muta T; Iwasaki H; Ogawa R; Eto T; Akashi K; Miyamoto T
    Ann Hematol; 2019 Nov; 98(11):2579-2591. PubMed ID: 31628517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
    Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
    Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.